HOME >> BIOLOGY >> NEWS
Double trouble for RA patients: PLC-gamma-2 regulates osteoclastogenesis and B cell differentiation

Rheumatoid arthritis (RA) is best known as a chronic inflammatory disease caused by the immune system inappropriately attacking the joints. However, the autoimmune response also leads to the recruitment and/or differentiation of cells known as osteoclasts -- which are cells that degrade and resorb bone. Current treatments for patients with RA target either the joint-specific immune response or the osteoclast-mediated bone erosion.

Now, in a study appearing online on October 19 in advance of publication in the November print issue of the Journal of Clinical Investigation, researchers from Washington University have shown that the protein PLC-gamma-2, which was already known to regulate the differentiation of B cells (one of the immune cells crucial to the autoimmune response seen in RA), is required for normal osteoclast development and function in mice. Roberta Faccio and colleagues therefore suggest that targeting PLC-gamma-2 might lead to control of both the immune-mediated joint destruction and osteoclast-mediated bone erosion seen in RA.


'"/>

Contact: Karen Honey
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
19-Oct-2006


Page: 1

Related biology news :

1. Double identities lie behind chromosome disorders
2. Double honors for diabetes researchers
3. Double honor recognises world-class science and spin-out success
4. Double-trouble: Cells with duplicate genomes can trigger tumors
5. Double trouble: Cells with duplicate genomes can trigger tumors
6. Double triumph in stem cell quest
7. Too much weight spells double trouble for couples trying to conceive
8. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
9. No trouble removing oil from water
10. Marine researchers deliver blueprint for rescuing Americas troubled coral reefs
11. Vampire bats keep out of trouble by running

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... June 04, 2020 , ... Greffex, a pioneering vaccine and gene ... Directors. , “Neil understands the need for a global perspective to make an impact ... Greffex. Mr. Bush will serve as an independent, director of the company. , “The ...
(Date:5/30/2020)... ... 29, 2020 , ... eInfochips, a leading provider of product ... EchoNous Inc. to develop the cloud-based connected health KOSMOS platform that has been ... been clinically tested versus expert measurements, yielding improved results in precision and consistency. ...
(Date:5/28/2020)... ... 27, 2020 , ... Today bioinformatics leader hc1® ... combines lab testing insights and hc1’s exclusive Local Risk Index in a unified ... of employees returning to the workplace. , “Some of the best ways to ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... ... will cause long-term harm , Contrary to conventional wisdom that says the coronavirus ... finds many companies will emerge from the pandemic commercially weaker, dealing with delays ...
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased to announce ... and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm. , This ... United States, linking US and Asia Pacific healthcare innovators with capital and investors. , ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, ... streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the ...
(Date:5/15/2020)... ... ... This new service offers clients a way to speak with Subject Matter Experts ... arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of scientific, technical, ... are available normal business hours Monday through Friday from 9:00 am – 5:00 pm ...
Breaking Biology Technology:
Cached News: